These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24084403)

  • 41. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
    Wheeler E; Jones TS; Gilbert MK; Davidson PJ;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):631-5. PubMed ID: 26086633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prescription drug monitoring and dispensing of prescription opioids.
    Brady JE; Wunsch H; DiMaggio C; Lang BH; Giglio J; Li G
    Public Health Rep; 2014; 129(2):139-47. PubMed ID: 24587548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model.
    Kumar VM; Agboola F; Synnott PG; Segel C; Webb M; Ollendorf DA; Banken R; Chapman RH
    Value Health; 2019 Apr; 22(4):416-422. PubMed ID: 30975392
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines.
    Jones CM; McAninch JK
    Am J Prev Med; 2015 Oct; 49(4):493-501. PubMed ID: 26143953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmaceutical Opioids in the Home and Youth: Implications for Adult Medical Practice.
    Binswanger IA; Glanz JM
    Subst Abus; 2015; 36(2):141-3. PubMed ID: 25671706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose?
    Bannwarth B
    Drugs; 2012 Sep; 72(13):1713-23. PubMed ID: 22931520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
    Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
    Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.
    Coplan PM; Chilcoat HD; Butler SF; Sellers EM; Kadakia A; Harikrishnan V; Haddox JD; Dart RC
    Clin Pharmacol Ther; 2016 Sep; 100(3):275-86. PubMed ID: 27170195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009.
    Calcaterra S; Glanz J; Binswanger IA
    Drug Alcohol Depend; 2013 Aug; 131(3):263-70. PubMed ID: 23294765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States.
    Iwanicki JL; Severtson SG; McDaniel H; Rosenblum A; Fong C; Cicero TJ; Ellis MS; Kurtz SP; Buttram ME; Dart RC
    PLoS One; 2016; 11(12):e0167499. PubMed ID: 27936038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Legal pot, lower opioid death rate.
    Minn Med; 2015 May; 98(5):7. PubMed ID: 26065172
    [No Abstract]   [Full Text] [Related]  

  • 52. Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality.
    Phillips E; Gazmararian J
    J Opioid Manag; 2017; 13(4):229-239. PubMed ID: 28953315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How Massachusetts, Vermont, and New York Are Taking Action to Address the Opioid Epidemic.
    Hernandez Y; Meyers-Ohki S; Farkas S; Ball S; Leonard K; Rotrosen J; Saitz R
    Am J Public Health; 2018 Dec; 108(12):1621-1622. PubMed ID: 30403507
    [No Abstract]   [Full Text] [Related]  

  • 54. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
    Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
    JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose.
    Haegerich TM; Paulozzi LJ; Manns BJ; Jones CM
    Drug Alcohol Depend; 2014 Dec; 145():34-47. PubMed ID: 25454406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study.
    Hsu G; Kovács B
    BMJ; 2021 Jan; 372():m4957. PubMed ID: 33504472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do more robust prescription drug monitoring programs reduce prescription opioid overdose?
    Pardo B
    Addiction; 2017 Oct; 112(10):1773-1783. PubMed ID: 28009931
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-risk use by patients prescribed opioids for pain and its role in overdose deaths.
    Gwira Baumblatt JA; Wiedeman C; Dunn JR; Schaffner W; Paulozzi LJ; Jones TF
    JAMA Intern Med; 2014 May; 174(5):796-801. PubMed ID: 24589873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An epidemic of the use, misuse and overdose of opioids and deaths due to overdose, in the United States and Canada: is Europe next?
    Helmerhorst GT; Teunis T; Janssen SJ; Ring D
    Bone Joint J; 2017 Jul; 99-B(7):856-864. PubMed ID: 28663389
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.